Literature DB >> 15310524

REM sleep behavior disorder: clinical and physiopathological findings.

E Sforza1, J Krieger, C Petiau.   

Abstract

Abnormalities of REM sleep i.e. absence of atonia and abnormal motor control which are described in patients with REM sleep behavior disorder, have induced clinical and physiopathological interest. Initial hypothesis of a simple dysfunction of REM sleep generators has not been confirmed. The prevalence in older subjects and in patients with parkinsonian syndromes suggest that the appearance of the parasomnia is related to alteration in the neurons of pontine area i.e. nucleus peduncolopontine, in which there is an integration of sleep-wake mechanisms and locomotor systems. Controversy surrounds the specificity of absence of atonia in the diagnosis of the parasomnia. Since this polygraphic finding may be present in subjects without any sleep complaint and in patients with initial neurological impairment, diagnosis of the sleep disorders might be allowed only when the polygraphic characteristic of persistent tonus and complex motor behavior are recorded.

Entities:  

Year:  1997        PMID: 15310524     DOI: 10.1016/s1087-0792(97)90006-x

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  24 in total

Review 1.  REM sleep behaviour disorder in older individuals: epidemiology, pathophysiology and management.

Authors:  Lynn Marie Trotti
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

2.  Sleep and Its Disorders in Seniors.

Authors:  Carl J Stepnowsky; Sonia Ancoli-Israel
Journal:  Sleep Med Clin       Date:  2008

3.  Best practice guide for the treatment of REM sleep behavior disorder (RBD).

Authors:  R Nisha Aurora; Rochelle S Zak; Rama K Maganti; Sanford H Auerbach; Kenneth R Casey; Susmita Chowdhuri; Anoop Karippot; Kannan Ramar; David A Kristo; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2010-02-15       Impact factor: 4.062

4.  Amelioration of obstructive sleep apnea in REM sleep behavior disorder: implications for the neuromuscular control of OSA.

Authors:  Jixiong Huang; Jihui Zhang; Siu Ping Lam; Shirley Xin Li; Crover Kwok Wah Ho; Venny Lam; Mandy Wai Man Yu; Yun-Kwok Wing
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

5.  Normal and abnormal sleep in the elderly.

Authors:  Jana R Cooke; Sonia Ancoli-Israel
Journal:  Handb Clin Neurol       Date:  2011

Review 6.  REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions.

Authors:  Bradley F Boeve
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 7.  REM sleep behavior disorder, autonomic dysfunction and synuclein-related neurodegeneration: where do we stand?

Authors:  Giacomo Chiaro; Giovanna Calandra-Buonaura; Annagrazia Cecere; Francesco Mignani; Luisa Sambati; Giuseppe Loddo; Pietro Cortelli; Federica Provini
Journal:  Clin Auton Res       Date:  2017-09-04       Impact factor: 4.435

8.  Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.

Authors:  B F Boeve; M H Silber; T J Ferman; S C Lin; E E Benarroch; A M Schmeichel; J E Ahlskog; R J Caselli; S Jacobson; M Sabbagh; C Adler; B Woodruff; T G Beach; A Iranzo; E Gelpi; J Santamaria; E Tolosa; C Singer; D C Mash; C Luca; I Arnulf; C Duyckaerts; C H Schenck; M W Mahowald; Y Dauvilliers; N R Graff-Radford; Z K Wszolek; J E Parisi; B Dugger; M E Murray; D W Dickson
Journal:  Sleep Med       Date:  2013-03-07       Impact factor: 3.492

Review 9.  Sleep and aging: 1. Sleep disorders commonly found in older people.

Authors:  Norman Wolkove; Osama Elkholy; Marc Baltzan; Mark Palayew
Journal:  CMAJ       Date:  2007-04-24       Impact factor: 8.262

10.  Rapid eye movement sleep behavior disorder in adults younger than 50 years of age.

Authors:  Yo-El S Ju
Journal:  Sleep Med       Date:  2013-01-21       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.